The open index of psychedelic research

Baseline Response Criterion and Changes in Emotional Bias as Markers of Esketamine Response in Treatment-Resistant Depression

Muh C, Favre P, Lutkenherm IK +3

Contexts, Risks, and Affordances among Autistic Adults Using Psychedelics for Therapeutic Purposes: A Naturalistic, Mixed-Methods Study

Intranasal Esketamine for Treatment-Resistant Depression: A Practical Clinical Guide to Patient Selection, Dosing, Combination Strategies and Adverse-Event Management

De Berardis D, Barlattani T, Carano A +10

Group psilocybin in an integrative retreat setting enhances social connection: an observational case report

Rayford D, Dayal S, Boudreau K +3

Group psilocybin in an integrative retreat setting enhances social connection: an observational case report

Rayford D, Dayal S, Boudreau K +3

Efficacy and Safety of Intranasal Dexmedetomidine Combined with Esketamine for Premedication in Children Undergoing Laser Treatment for Burn Scars: A Randomised Self-Controlled Crossover Trial

S, Cao J, Liu P +2

Language-associated brain representations covary with disruption of selfhood under psilocybin

Cooper G, Stoliker D, Astl Delgado SV +6

Mescaline distribution and concentration in Trichocereus bridgesii

Engel L, Hall DR, Skene D +3

Quality of Life and the Case for Consent-Based Psilocybin Access – Questions on the Regulatory Framework and Cost

Ancans J

White Matter Microstructure and Psilocybin Treatment for OCD: Baseline Associations, Longitudinal Change, and Link to Symptom Response

Neurite Complexity and Plasticity Markers Track Synaptic Vesicle Density in the Living Human Brain: A Multimodal PET-MRI-EEG Study

Agnorelli C, Peill J, Kurtin DL +25

Ketamine and Super Refractory Status Epilepticus in Adults: A Scoping Review

Pharmacokinetic disposition in oral fluid, excretion profile, and subjective and physiological responses following oral and intranasal administration of Clophedrone (3-CMC)

La Maida N, Poyatos L, Trana AD +12

Dizocilpine-derived K2060 exhibits enhanced blockage at NMDA receptors with impaired Mg2+ block and provides strong protection against audiogenic seizures

Kolcheva M, Netolicky J, Misiachna A +14

U.S. Health System Readiness to Adopt Classic Psychedelic-Assisted Therapy for People with Serious Illness: A Scoping Review

Clinical Effects of Low-Dose Esketamine During Emergency Conversion From Labor Epidural Analgesia to Category I Cesarean Section: A Randomized Controlled Trial of Maternal Hemodynamics, Analgesia, Sedation, and Neonatal Outcomes

Liang W, Zhai L

Are you “the medicine”? Intention category and explicitness as predictors of perceived outcomes associated with psychedelic experiences

Mosina I, Luke D

Psilocybin-Assisted Therapy for Existential Distress in Serious and Life-Limiting Illness: Emerging Trial Evidence, Barriers to Access, and the Case for Individualized Eligibility

Ancans J

Ayahuasca plant genomes reveal retrotransposon-derived centromeres and contrasting routes to DMT and β-carbolines

Qiu R, Mann SGA, Nascimento T +14

Serotonin _2A receptors in the medial prefrontal cortex do not drive DOI-induced head-twitch responses in rodents

Vuruputuri RM, Reghunath V, Mukherjee S +4

Ketadex Versus Ketofol for Adult Procedural Sedation in the Emergency Department.

Molecular Mechanism of Psilocybin-Induced Longevity: The c-Fos–SIRT6 Epigenetic Axis

Lakshmanane B

Ketamine and esketamine during breastfeeding: a systematic review of human pharmacokinetic, infant and lactation outcomes.

Olivola M, Martiadis V, Prodi T +6

Subcutaneous Esketamine in Adolescents with Severe Depressive Episodes: A Five-Case Series.

Magalhães IPA, Lopes DN, Amato IA +6